• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
'Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM' - Author's reply.“在炎症标志物升高的住院COVID-19患者中早期使用托珠单抗；COVIDSTORM”——作者回复
Clin Microbiol Infect. 2022 Nov;28(11):1520-1521. doi: 10.1016/j.cmi.2022.06.028. Epub 2022 Jul 4.
2
Re: Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM.回复：在炎症标志物升高的住院COVID-19患者中早期使用托珠单抗；COVIDSTORM研究。
Clin Microbiol Infect. 2022 Nov;28(11):1519. doi: 10.1016/j.cmi.2022.06.013. Epub 2022 Jun 20.
3
Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM-a prospective, randomized, single-centre, open-label study.COVID-19 住院患者炎症标志物升高时早期使用托珠单抗；COVIDSTORM 前瞻性、随机、单中心、开放标签研究。
Clin Microbiol Infect. 2022 Jun;28(6):844-851. doi: 10.1016/j.cmi.2022.02.027. Epub 2022 Mar 5.
4
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis - Author's reply.托珠单抗治疗新冠肺炎患者的疗效和安全性：一项实时系统评价与荟萃分析——作者回复
Clin Microbiol Infect. 2021 Aug;27(8):1177-1178. doi: 10.1016/j.cmi.2021.02.024. Epub 2021 Mar 8.
5
Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection.托珠单抗使用时机对住院的2019冠状病毒病感染患者的影响
Respir Care. 2022 May;67(5):629-630. doi: 10.4187/respcare.10067.
6
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.托珠单抗治疗新冠病毒肺炎住院患者
N Engl J Med. 2021 Apr 15;384(15):1473. doi: 10.1056/NEJMc2100217. Epub 2021 Mar 3.
7
Benign SARS-CoV-2 infection in MOG-antibodies associated disorder during tocilizumab treatment.托珠单抗治疗期间伴 MOG 抗体相关疾病的良性 SARS-CoV-2 感染。
Mult Scler Relat Disord. 2020 Nov;46:102592. doi: 10.1016/j.msard.2020.102592. Epub 2020 Oct 21.
8
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. Reply.托珠单抗用于新冠肺炎肺炎住院患者。回复。
N Engl J Med. 2021 Apr 15;384(15):1473-1474. doi: 10.1056/NEJMc2100217. Epub 2021 Mar 3.
9
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. Reply.托珠单抗用于新冠肺炎肺炎住院患者。回复。
N Engl J Med. 2021 Apr 15;384(15):1474. doi: 10.1056/NEJMc2100217. Epub 2021 Mar 3.
10
Dosing and Administration Strategies of Tocilizumab in Patients With COVID-19: A Retrospective Cohort Analysis.托珠单抗在 COVID-19 患者中的剂量和给药策略：一项回顾性队列分析。
Ann Pharmacother. 2024 Apr;58(4):391-397. doi: 10.1177/10600280231190401. Epub 2023 Jul 31.

引用本文的文献

1
Complex changes in serum protein levels in COVID-19 convalescents.新型冠状病毒肺炎恢复期患者血清蛋白水平的复杂变化。
Sci Rep. 2024 Feb 23;14(1):4479. doi: 10.1038/s41598-024-54534-7.

本文引用的文献

1
Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM-a prospective, randomized, single-centre, open-label study.COVID-19 住院患者炎症标志物升高时早期使用托珠单抗；COVIDSTORM 前瞻性、随机、单中心、开放标签研究。
Clin Microbiol Infect. 2022 Jun;28(6):844-851. doi: 10.1016/j.cmi.2022.02.027. Epub 2022 Mar 5.

'Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM' - Author's reply.

作者信息

Broman Niklas, Feuth Thijs, Oksi Jarmo

机构信息

Departments of Infectious Diseases and Pulmonary Diseases, Turku University Hospital, Turku, Finland.

Departments of Infectious Diseases and Pulmonary Diseases, Turku University Hospital, Turku, Finland.

出版信息

Clin Microbiol Infect. 2022 Nov;28(11):1520-1521. doi: 10.1016/j.cmi.2022.06.028. Epub 2022 Jul 4.

DOI:10.1016/j.cmi.2022.06.028
PMID:35798145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9250883/
Abstract
摘要